Past Data Requests

Name of requestor
Doctoral Student, University of Washington, Department of Medicine
Date of request
Request status
Pending
Data requested

Custom Data File

Reason for approval/denial
Fees
Purpose of request

The purpose of this study is to elucidate the effects of the COVID-19 pandemic on the health outcomes of individuals living with alcohol-associated liver disease (ALD) or alcohol-associated cir20rhosis (AC) in Washington State. To this end, our primary aim is to describe and compare rates of hospitalization due to complications of ALD or AC in Washington State between 2019 and 2020.  The burden of ALD is high and rising; ALD is now the leading cause of chronic liver disease (CLD) and most common indication for liver transplantation in the United States. ALD is an “ambulatory care-sensitive” condition. Optimal outpatient management can slow disease progression; decrease utilization of emergency services; and decrease rates of hospitalization and mortality. However, the COVID-19 pandemic has limited in-person ambulatory services, with varying degrees of restrictions across the United States. Telemedicine became a primary conduit of outpatient care; however, concerns regarding equitable access and long-term health outcomes remain. To our knowledge, there are currently no studies that characterize the burden of hospitalizations for ALD/AC in Washington State during the COVID-19 pandemic. The results of this study will contribute to literature on the impact of the COVID-19 pandemic on health outcomes for patients with ALD/AC. Study findings will aid efforts to continue to characterize and predict the short- and long-term outcomes of the pandemic on at-risk populations, particularly in Washington State. Our findings will support the development of recommendations to target resources towards preventative services to address the unique needs of patients living with ALD/AC.

Includes Protected Health Information (PHI) or proprietary financial information

PHI; Public Comment Period ended